Aug 22, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Thermo Fisher ( TMO ) Up 1.8% Since Last Earnings Report: Can It Continue?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aug 21, 2025 • Benzinga
SOMEWHAT-BULLISH
[Latest] Global Induced Pluripotent Stem Cells Production Market Size/Share Worth USD 4.34 Billion by 2034 at a 9.5% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT )
Austin, TX, USA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Induced Pluripotent Stem Cells Production Market Size, Trends and Insights By Process ( Manual iPSC Production, Automated iPSC Production ) , By Workflow ( Cell Culture, Cell ...
Aug 20, 2025 • Benzinga
SOMEWHAT-BULLISH
Genome Editing Market to Grow at 16.9% CAGR Through 2030
Boston, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Genome Editing: Technologies and Global Markets" is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 16.9% during the ...
Aug 19, 2025 • Motley Fool
SOMEWHAT-BULLISH
Why Thermo Fisher Scientific Stock Was Topping the Market Today
According to one pundit, the company has a hard-to-beat mix of quality products and services.
Aug 19, 2025 • Benzinga
SOMEWHAT-BULLISH
Thermo Fisher Positioned As Biopharma's Partner Of Choice - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher stock is projected to reach $598 by 2026, offering 22% upside. Shares have fallen 27% since 2021, trailing the S&P's 30% gain, but the long-term outlook is strong. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Aug 19, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence ( COE ) for NGS Diagnostics
Biodesix recently validated Thermo Fisher's tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer Biodesix recently validated Thermo Fisher's tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer ...